Methods of treating secondary bone tumors with antibodies against PDGFR alpha
US8425911B2 · kind B2 · utility
0Cited by
48References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 19, 2011 |
| Grant date | Apr 23, 2013 |
| Priority date | — |
| Expiry date | Oct 19, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods of treating bone cancer, particularly metastatic bone cancer, by administering a PDGFR alpha antagonist. The invention further provides methods of treating a mammal with a neoplastic disease using the antibodies alone or in combination with other agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.